UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...

Lenders report that default rates on secured loans to UK households increased in Q3 2024 and are expected to increase again ...

GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...

GSK shares top the Stoxx Europe 600 index on Thursday after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn ...

The superstorm is expected to inflict costly and lasting damage in Florida, as the Federal Reserve is already keeping an eye ...

Chinese stock markets returned to winning ways Thursday, closing with solid gains after China's central bank took action to ...

GlaxoSmithKline (GSK) saw its shares jump more than 6% after the pharmaceutical giant announced a settlement of up to $2.2 ...

The FTSE 100 index traded down 7.91 points, 0.1%, at 8,235.83. The FTSE 250 slipped 63.88 points, 0.3%, at 20,758.50, and the AIM All-Share down 2.18 points, 0.3%, at 734.48.

GSK shares in London jumped 5% Thursday after the British drug giant said it has resolved most of the U.S. lawsuits it faced ...